State of Wisconsin Investment Board
INSY

State of Wisconsin Investment Board’s Insys Therapeutics, Inc. INSY Stock Holding History

State of Wisconsin Investment Board’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36,000
Closed -$166K – 1646
2019
Q1 		$166K Buy
36,000
+8,200
+29% +$38.8K ﹤0.01% 1475
2018
Q4 		$97K Buy
27,800
+8,800
+46% +$61.2K ﹤0.01% 1498
2018
Q3 		$192K Hold
19,000
– – ﹤0.01% 1504
2018
Q2 		$138K Hold
19,000
– – ﹤0.01% 1446
2018
Q1 		$115K Hold
19,000
– – ﹤0.01% 1428
2017
Q4 		$183K Hold
19,000
– – ﹤0.01% 1393
2017
Q3 		$169K Hold
19,000
– – ﹤0.01% 1410
2017
Q2 		$240K Buy
+19,000
New +$225K ﹤0.01% 1386

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

State of Wisconsin Investment Board's INSY Position: Q2 2019 in Review

State of Wisconsin Investment Board sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 36,000 shares — an estimated $166K sold.

State of Wisconsin Investment Board first reported a position in INSY in Q2 2017 and held it in 8 quarters. The position peaked at $240K in Q2 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • State of Wisconsin Investment Board reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 36,000 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $166K.
  • State of Wisconsin Investment Board first reported a position in Insys Therapeutics, Inc. in Q2 2017 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Insys Therapeutics, Inc. position peaked at $240K in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.